No CrossRef data available.
Article contents
Cerebrovascular disease: a clinical approach
Published online by Cambridge University Press: 17 November 2008
Abstract
An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
- Type
- Clinical geriatrics
- Information
- Copyright
- Copyright © Cambridge University Press 1994
References
1National Institute of Neurological Disorders and Stroke. Classification of cerebrovascular diseases III. Stroke 1990; 21: 637–76.Google Scholar
2Hankey, GJ, Warlow, CP. Transient ischaemic attacks of the brain and eye. London: Baillière Tindall, WB Saunders, 1994.Google Scholar
3Dennis, MS, Bamford, JM, Sandercock, PAG, Molyneux, A, Warlow, CP. Computerised tomography in patients with transient ischaemic attacks: when is a transient ischaemic attack not a transient ischaemic attack but a stroke? J Neurol 1990; 237: 257–61.CrossRefGoogle Scholar
4Hatano, S. Experience from a multicentre stroke register: a preliminary report. Bull World Health Organ 1976; 54: 541–53.Google Scholar
5Bamford, J, Sandercock, P, Dennis, M, Burn, J, Warlow, C. A prospective study of acute cerebrovascular disease in the community: the Oxfordshire Community Stroke Project-1981–1986. Incidence, case fatality rates and overall outcome at one year of cerebral infarction, primary intracerebral haemorrhage and subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry 1990; 53: 16–22.Google Scholar
6Anderson, CS, Jamrozik, KD, Burvill, PW, Chakera, TMH, Johnson, GA, Stewart-Wynne EG: Determining the incidence of different subtypes of stroke: results from the Perth Community Stroke study, 1989–1990. Med J Aust 1993; 158: 85–89.CrossRefGoogle ScholarPubMed
7Dennis, MS, Bamford, JM, Sandercock, PAG, Warlow, CP. A comparison of risk factors and prognosis for transient ischaemic attacks and minor ischaemic strokes. The Oxfordshire Community Stroke Project. Stroke 1989; 20: 1494–99.CrossRefGoogle ScholarPubMed
8Dennis, M, Bamford, J, Sandercock, P, Warlow, C. Prognosis of transient ischaemic attacks in the Oxfordshire Community Stroke Project. Stroke 1990; 21: 848–53.CrossRefGoogle ScholarPubMed
9Hankey, GJ, Slattery, JM, Warlow, CP. The prognosis of hospital-referred transient ischaemic attacks. J Neural Neurosurg Psychiatry 1991; 54: 793–802.Google Scholar
10Dennis, MS, Burn, JPS, Sandercock, PAG, Bamford, JM, Wade, DT, Warlow, CP. Long-term survival after first-ever stroke: the Oxfordshire Community Stroke Project. Stroke 1993; 24: 796–800.CrossRefGoogle ScholarPubMed
11Erkinjuntti, T, Hachinski, VC: Rethinking vascular dementia. Cerebrovasc Dis 1993; 3: 3–23.CrossRefGoogle Scholar
13Martin, J, Meltzer, H, Elliot, D. For the Office of population censuses and surveys: OPCS surveys of disability in Great Britain, Report 1. The prevalence of disability among adults. London: HMSO, 1988.Google Scholar
14Bamford, J, Sandercock, P, Dennis, M et al. A prospective study of acute cerebrovascular disease in the community: the Oxfordshire Community Stroke Project-1981–1986. Methodology, demography and incident cases of first-ever stroke. J Neurol Neurosurg Psychiatry 1988; 51: 1373–80.CrossRefGoogle ScholarPubMed
15Anderson, CS, Jamrozik, KD, Burvill, PW, Chakera, TMH, Johnson, GA, Stewart-Wynne EG. Ascertaining the true incidence of stroke: experience from the Perth Community Stroke Study, 1989–1990. Med J Aust 1993; 158: 80–84.CrossRefGoogle ScholarPubMed
16Wade, DT, Langton-Hewer, R, Skilbeck, CE, David, RM. Stroke. A critical approach to diagnosis, treatment and management. London: Chapman & Hall, 1985.Google Scholar
17Bonita, RB, Beaglehole, R. Explaining stroke mortality trends. Lancet 1993; 341: 1510–11.CrossRefGoogle ScholarPubMed
18Malmgren, R, Bamford, J, Warlow, C, Sandercock, P, Slattery, J. Projecting the number of patients with first-ever strokes and patients newly handicapped by stroke in England and Wales. Br Med J 1989; 298: 656–60.CrossRefGoogle ScholarPubMed
19Carstairs, V. Stroke: resource consumption and the cost to the community. In: Gillingham, FJ, Mawdsley, C, Williams, AE eds. Stroke proceedings of the ninth international Pfizer symposium. Edinburgh: Churchill Livingstone, 1976: 516–28.Google Scholar
20Isard, PA, Forbes, JF. The cost of stroke to the National Health Service in Scotland. Cerebrovasc Dis 1992; 2: 47–50.CrossRefGoogle Scholar
21Hankey, GJ, Warlow, CP. The role of imaging in the management of cerebral and ocular ischaemia. Neuroradiology 1991; 33: 381–90.CrossRefGoogle ScholarPubMed
22Dennis, MS, Bamford, JM, Sandercock, PAG, Warlow, CP. Incidence of transient ischaemic attacks in Oxfordshire, England. Stroke 1989; 20: 333–39.CrossRefGoogle ScholarPubMed
23Kraaijeveld, CL, van Gijn, J, Schouten, HJA, Staal, A. Interobserver agreement for the diagnosis of transient ischaemic attacks. Stroke 1984; 15: 723–25.CrossRefGoogle Scholar
24Kessler, C, Freyberger, HJ, Dittmann, V, Ringelstein, EB. Interrater reliability in the assessment of neurovascular diseases. Cerebrovasc Dis 1991; 1: 43–48.Google Scholar
25Dennis, MS, Warlow, CP. Migraine aura without headache: transient ischaemic attack or not? J Neural Neurosurg Psychiatry 1992; 55: 437–40.Google Scholar
26Olesen, J, Friberg, L, Olsen, TK et al. Ischaemia-induced (symptomatic) migraine attacks may be more frequent than migraine-induced ischaemic insults. Brain 1993; 116: 187–202.CrossRefGoogle ScholarPubMed
27O'Sullivan, F, Rossor, M, Elston, JS. Amaurosis fugax in young people. Br J Ophthalmol 1992; 76: 660–62.CrossRefGoogle ScholarPubMed
28Rao, ML, Stefan, H, Bauer, J. Epileptic but not psychogenic seizures are accompanied by simultaneous elevation of serum pituitary hormones and cortisol levels. Neuroendocrinology 1989; 49: 33–39.CrossRefGoogle Scholar
29Hodges, JR, Warlow, CP. Syndromes of transient amnesia: towards a classification. A study of 153 cases. J Neural Neurosurg Psychiatry 1990; 53 834–43.CrossRefGoogle ScholarPubMed
30UK-TIA Study Group. Intracranial tumours that mimic transient cerebral ischaemia: lessons from a large multicentre trial. J Neural Neurosurg Psychiatry 1993; 56: 563–66.CrossRefGoogle Scholar
31Bogousslavsky, J, Vinuela, F, Barnett, HJM, Drake, CG: Amaurosis fugax as the presenting manifestation of dural arteriovenous malformation. Stroke 1985; 16: 891–93.Google Scholar
32Moster, ML, Johnston, DE, Reinmuth, OM. Chronic subdural haematoma with transient neurological deficits: a review of 15 cases. Ann Neurol 1983; 14: 539–42.CrossRefGoogle ScholarPubMed
33Twomey, JA, Espir, MLE. Paroxysmal symptoms as the first manifestations of multiple sclerosis. J Neural Neurosurg Psychiatry 1980; 43: 296–304.CrossRefGoogle ScholarPubMed
34Rother, J, Schreiner, A, Wentz, K-U, Hennerici, M. Hypoglycaemia presenting as basilar artery thrombosis. Stroke 1992; 23: 112–13.CrossRefGoogle ScholarPubMed
35Longo, DL, Witherspoon, JM. Focal neurological symptoms in hypercalcaemia. Neurology 1980; 30: 200–201.CrossRefGoogle Scholar
36Ruby, RJ, Burton, JR. Acute reversible hemiparesis and hyponatraemia. Lancet 1977; 1: 1212.Google Scholar
37Dawson, DM, Hallett, M, Millender, LH. Entrapment neuropathies, second edition. Boston: Little, Brown & Co, 1990: 333.Google Scholar
38Blau, JN, Wiles, CM, Solomon, FS. Unilateral somatic symptoms due to hyperventilation. Br Med J 1983; 286: 1108.CrossRefGoogle ScholarPubMed
39Bogousslavsky, J, Regli, F. Vertebrobasilar transient ischaemic attacks in internal carotid artery occlusion or tight stenosis. Arch Neurol 1985; 42: 64–68.CrossRefGoogle ScholarPubMed
40Sandercock, PAG, Allen, CMC, Corston, RN, Harrison, MJG, Warlow, CP. Clinical diagnosis of intracranial haemorrhage using Guy's Hospital score. Br Med J 1985; 291: 1675–77.CrossRefGoogle ScholarPubMed
41Poungvarin, N, Viriyavejakul, A, Komontri, C. Siriraj stroke score and validation study to distinguish supratentorial intracerebral haemorrhage from infarction. Br Med J 1991; 302: 1565–67.Google Scholar
42Donnan, GA. Investigation of patients with stroke and transient ischaemic attacks. Lancet 1992; 339: 473–77.CrossRefGoogle ScholarPubMed
43Dennis, MS, Bamford, JM, Molyneux, AJ, Warlow, CP. Rapid resolution of signs of primary intracerebral haemorrhage in computed tomograms of the brain. Br Med M 1987;295: 379–81.CrossRefGoogle ScholarPubMed
44Edelman, RR, Warach, S. Magnetic resonance imaging (second of two parts). N Engl J Med 1993; 328: 785–91.Google Scholar
45Hopkins, A, Menken, M, DeFriese, GH, Feldman, RG. Differences in strategies for the diagnosis and treatment of neurologic disease among British and American neurologists. Arch Neurol 1989; 46: 1142–48.Google Scholar
46UK-TIA Study Group. Variation in the use of angiography and carotid endarterectomy by neurologists in the UK-TIA Aspirin Trial. Br Med J 1983; 286: 514–17.Google Scholar
47Hankey, GJ, Warlow, CP. Cost-effective investigation of patients with suspected transient ischaemic attacks. J Neural Neurosurg Psychiatry 1992; 55: 171–76.CrossRefGoogle ScholarPubMed
50Donnan, GA, Bladin, PF, Berkovic, SF, Longley, WA, Saling, MM. The stroke syndrome of striatocapsular infarction. Brain 1991; 114: 51–70.Google ScholarPubMed
51Hankey, GJ, Warlow, CP. Lacunar transient ischaemic attacks: a clinically useful concept? Lancet 1991; 337: 335–38.Google Scholar
52Hommel, M, Besson, G, Le Bas, JF et al. Prospective study of lacunar infarction using magnetic resonance imaging. Stroke 1990; 21: 546–54.Google Scholar
53Waterston, JA, Brown, MM, Butler, P, Swash, M. Small deep cerebral infarcts associated with occlusive internal carotid artery disease. Arch Neurol 1990; 47: 953–57.Google Scholar
54Hankey, GJ, Khangure, MS, Stewart-Wynne, EG. Detection of basilar artery thrombosis by computed tomography. Clin Radiol 1988; 39: 140–43.CrossRefGoogle ScholarPubMed
55Virapongse, C, Cazenave, C, Quisling, R, Sarwar, M, Hunter, S. The empty delta sign. Frequency and significance in 76 cases of dural sinus thrombosis. Radiology 1987; 162: 779–85.Google Scholar
56Woo, J, Lam, CWK, Kay, R, Wong, HY, Teoh, R, Nicholls MG. Acute and long-term changes in serum lipids after acute stroke. Stroke 1990; 21: 1407–11.CrossRefGoogle ScholarPubMed
57Sandercock, PAG, Warlow, CP, Jones, LN, Starkey, IR. Predisposing factors for cerebral infarction: the Oxfordshire community stroke project. Br Med J 1989; 298: 75–80.Google Scholar
58Hughes, GRV: The antiphospholipid syndrome: ten years on. Lancet 1993; 342: 341–44.CrossRefGoogle Scholar
59Greaves, M. Coagulation abnormalities and cerebral infarction. J Neurol Neurosurg Psychiatry 1993; 56: 433–39.Google Scholar
60European Carotid Surgery Trialists' Collaborative Group. MRC European Carotid Surgery Trial: interim results for symptomatic patients with severe (70–99%) or with mild (0–29%) carotid stenosis. Lancet 1991; 337: 1235–43.CrossRefGoogle Scholar
61North American Symptomatic Carotid Endarterectomy Trial (NASCET) collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med 1991; 325: 445–53.CrossRefGoogle Scholar
62Hankey, GJ, Warlow, CP. Symptomatic carotid ischaemic events: safest and most cost-effective way of selecting patients for angiography, before carotid endarterectomy. Br Med J 1990; 300: 1485–91.Google Scholar
63Hu, H-H, Sheng, W-Y, Yen, M-Y, Lai, S-T, Teng, MM-H: Colour Doppler imaging of orbital arteries for detection of carotid occlusive disease. Stroke 1993;24: 1196–203.CrossRefGoogle ScholarPubMed
64Humphrey, P, Sandercock, P, Slattery, J. A simple method to improve the accuracy of non-invasive ultrasound in selecting TIA patients for cerebral angiography. J Neurol Neurosurg Psychiatry 1990; 53: 966–71.CrossRefGoogle ScholarPubMed
65Lewis, BD, James, EM, Welch, TJ. Current applications of Duplex and color Doppler ultrasound imaging: carotid and peripheral vascular system. Mayo Clin Proc 1989; 64: 1147–57.CrossRefGoogle ScholarPubMed
67Steinke, W, Hennerici, M, Rautenberg, W, Mohr, JP. Symptomatic and asymptomatic high-grade stenoses in Doppler colour-flow imaging. Neurology 1992; 42: 131–38.CrossRefGoogle Scholar
68Hankey, GJ, Warlow, CP, Sellar, RJ. Cerebral angiographie risk in mild cerebrovascular disease. Stroke 1990; 21: 209–22.CrossRefGoogle Scholar
69Hankey, GJ, Warlow, CP, Molyneux, AJ. Complications of cerebral angiography for patients with mild carotid territory ischaemia being considered for carotid endarterectomy. J Neurol Neurosurg Psychiatry 1990; 53: 542–48.CrossRefGoogle ScholarPubMed
70Davies, KN, Humphrey, PR. Complications of cerebral angiography in patients with symptomatic carotid territory ischaemia screened by carotid ultrasound. J Neurol Neurosurg Psychiatry 1993; 56: 967–72.CrossRefGoogle ScholarPubMed
71Hart, RG. Cardiogenic embolism to the brain. Lancet 1992; 339: 589–94.CrossRefGoogle ScholarPubMed
72DeRook, FA, Comess, KA, Albers, GW. Popp, RL. Transoesophageal echocardiography in the evaluation of stroke. Ann Intern Med 1992; 117: 922–32.Google Scholar
73Rose, G. The strategy of preventive medicine. Oxford: Oxford University Press, 1992.Google Scholar
74Shaper, AG, Phillips, AN, Pocock, SJ, Walker, M, Macfarlane, PW. Risk factors for stroke in middle aged British men. Br Med J 1991; 302: 1111–15.Google Scholar
75Donnan, GA, You, R, Thrift, A, McNeil, JJ. Smoking as a risk factor for stroke. Cerebrovasc Dis 1993; 3: 129–38.Google Scholar
76Alderman, MH. Blood pressure management: individualised treatment based on absolute risk and the potential for benefit. Ann Intern Med 1993; 119: 329–35.Google Scholar
77MacMahon, S, Peto, R, Cutler, J et al. Blood pressure, stroke, and coronary heart disease. Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990; 335: 765–74.CrossRefGoogle ScholarPubMed
78Collins, R, Peto, R, MacMahon, S et al. Blood pressure, stroke and coronary heart disease. Part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet 1990; 335: 827–38.Google Scholar
79Hankey, GJ, Slattery, JM, Warlow, CP. Transient ischaemic attacks: which patients are at high (and low) risk of serious vascular events? J Neural Neurosurg Psychiatry 1992; 55: 640–52.Google Scholar
80Antiplatelet Trialists Collaboration: Collaborative overview of randomised trials of antiplatelet therapy-I: prevention of death, myocardial infarction and stroke by prolonged antiplatelet therapy in various categories of patients. Br Med J 1994; 308: 81–106.CrossRefGoogle Scholar
81The SALT Collaborative Group (Britton, M, Elwin, C-E, Helmers, C et al. ) Swedish Aspirin Low-dose Trial (SALT) of 75 mg aspirin as secondary prophylaxis after cerebrovascular ischemie events. Lancet 1991; 338: 1345–49.Google Scholar
82The Dutch TIA Trial Study Group. A comparison of two doses of aspirin (30 versus 283 mg a day) in patients after a transient ischaemic attack or minor ischaemic stroke. N Engl J Med 1991; 325: 1261–66.CrossRefGoogle Scholar
83European Atrial Fibrillation Trial Study Group. Secondary prevention in nonrheumatic atrial fibrillation after transient ischaemic attack or minor stroke. Lancet 1993; 342: 1255–62.Google Scholar
84Petersen, P, Boysen, G, Godfredsen, J, Andersen, E, Andersen, B. Placebo-controlled randomized trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. Lancet 1988; 1: 175–79.Google Scholar
85The Stroke Prevention in Atrial Fibrillation Study Group. The stroke prevention in atrial fibrillation study: final results. Circulation 1991; 84: 527–39.CrossRefGoogle Scholar
86The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators. The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. N Engl J Med 1990; 323: 1505–11.CrossRefGoogle Scholar
87Connolly, SJ, Laupacis, A, Gent, M, Roberts, RS, Cairns, JA, Joyner, C, for the CAFA Study Coinvestigators. Canadian atrial fibrillation anticoagulation (CAFA) study. J Am Coll Cardiol 1991; 18: 349–55.CrossRefGoogle Scholar
88Ezekowitz, MD, Bridgers, SL, James, KE et al. for the Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation (SPINAF) Investigators. Warfarin in the prevention of stroke associated with atrial fibrillation. N Engl J Med 1992; 327: 1406–f12.CrossRefGoogle Scholar
89Stroke Prevention in Atrial Fibrillation Investigators. Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II Study. Lancet 1994; 343: 687–91.Google Scholar
90Stroke Prevention in Atrial Fibrillation Investigators. Predictors of thromboembolism in atrial fibrillation: clinical features of patients at risk. Ann Intern Med 1992; 116: 1–5.CrossRefGoogle Scholar
91Clagett, GP, Youkey, JR, Brigham, RA et al. Asymptomatic cervical bruit and abnormal ocular plethysmography: a prospective study comparing two approaches to management. Surgery 1984; 96: 823–30.Google ScholarPubMed
92The CASANOVA Study Group. Carotid surgery versus medical therapy in asymptomatic carotid stenosis. Stroke 1991; 22: 1229–35.Google Scholar
93Mayo Asymptomatic Carotid Endarterectomy Group. Results of a randomised controlled trial of carotid endarterectomy for asymptomatic carotid stenosis. Mayo Clin Proc 1992; 67: 513–18.CrossRefGoogle Scholar
94Hobson, RW II, Weiss, DG, Fields WS et al. and the Veterans Affairs Cooperative Group. Efficacy of carotid endarterectomy for asymptomatic carotid stenosis. N Engl J Med 1993; 328: 221–27.Google Scholar
95Asymptomatic Carotid Atherosclerosis Study Group. Study design for randomised prospective trial of carotid endarterectomy for asymptomatic atherosclerosis. Stroke 1989; 20: 844–49.CrossRefGoogle Scholar
96EC/IC Bypass Study Group. Failure of extracranial-intracranial arterial bypass to reduce the risk of ischaemic stroke. N Engl J Med 1985; 313: 1191–200.CrossRefGoogle Scholar
97Brown, MM, Butler, P, Gibbs, J, Swash, M, Waterston, J. Feasibility of percutaneous transluminal angioplasty for carotid artery stenosis. J Neurol Neurosurg Psychiatry 1990; 53: 238–43.Google Scholar
98Sandercock, P, Willems, H. Medical treatment of acute ischaemic stroke. Lancet 1992; 339: 537–39.CrossRefGoogle ScholarPubMed
99Wardlaw, JM, Warlow, CP. Thrombolysis in acute ischaemic stroke. Does it work? Stroke 1992; 23: 1826–39.CrossRefGoogle ScholarPubMed
100Sandercock, PAG, van den Belt, AGM, Lindley, RI, Slattery, J. Antithrombotic therapy in acute ischaemic stroke: an overview of the completed randomised trials. J Neurol Neurosurg Psychiatry 1993; 56: 17–25.Google Scholar
101Scatton, B, Carter, C, Benavides, J, Giroux, C. N-Methyl-D-Aspartate receptor antagonists: a novel therapeutic perspective for the treatment of ischaemic brain injury. Cerebrovasc Dis 1991; 1: 121–35.CrossRefGoogle Scholar
102Czlonkowska, A, Mendel, T, Baranska-Gieruszcak, M. Naloxone in acute ischaemic stroke: double blind controlled study. J Neurol 1990; 237: 153.Google Scholar
103Schmidley, JW. Free radicals in central nervous system ischaemia. Stroke 1990; 21: 1086–90.CrossRefGoogle Scholar
104Argentino, C, Sacchetti, ML, Toni, D et al. GM1 Ganglioside therapy in acute ischaemic stroke. Stroke 1989; 20: 1143–49.CrossRefGoogle Scholar
105Goldstein, LB, Davis, JN. Restorative neurology. Drugs and recovery following stroke. Stroke 1990; 21: 1636–39.Google Scholar
106Pickard, JD, Murray, GD, Illingworth, R et al. Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage. British aneurysm nimodipine trial. Br Med J 1989; 298: 636–42.CrossRefGoogle ScholarPubMed